QMSR vs ISO 13485: What Medtech Companies Need to Know in 2026

Quality managers in the medical device industry face increasingly complex decisions about which quality management standards to implement and maintain. Two frameworks consistently emerge at the center of these discussions: the Quality Management System Regulation (QMSR) and ISO 13485. Understanding their differences, overlaps, and strategic implications has become essential for medtech companies planning their regulatory approach for 2026 and beyond.

Understanding the Fundamentals

ISO 13485, is a voluntary international standard that provides a comprehensive framework for quality management systems for medical device manufacturing.  It is recognized as the global benchmark for medtech quality management.  Regulators across multiple continents reference it, It outlines how best to operate a medical device quality management system, based on effective risk management. Organizations can work with a certified registrar to obtain registration against the standard so their medtech brand is recognized by a preeminent authority as meeting universal requirements for safety and effectiveness.

The QMSR, represents the FDA’s recent update of 21CFR820.  The framework adopts ISO 13485 by reference.  This has essentially shifted the FDA’s inspection framework from that of the former QSIT method (Quality Systems Inpection Technique) to that of a framework based on effective risk management.  However, compliance to ISO 13485 alone will not be sufficient for a medtech organization to pass an FDA inspection.  The QMSR adds longstanding FDA requirements that pertain to complaints, reportable events, device registration & listing, and device labeling requirements, include requirements for Instructions for Use & Unique Device Identifiers (UDIs).

In our experience working with medtech companies across various stages of growth, the distinction between the regulatory requirements and voluntary standard creates the first strategic consideration quality managers must address.

Key Differences That Impact Your Quality Strategy

Regulatory Status and Enforcement

The QMSR, carries the full force of European law. Non-compliance results in direct regulatory consequences, including market access denial, product recalls, and financial penalties. European notified bodies evaluate QMSR compliance as part of the conformity assessment process, making adherence non-negotiable for EU market entry.

ISO 13485 certification, while not legally required in most markets, often becomes a practical necessity. We consistently see companies pursuing ISO 13485 certification because customers, partners, and other regulatory bodies recognize it as proof of robust quality management practices.

Scope and Application

The QMSR is the new FDA regulation, which recently began enforcement on 02 February 2026, superseding the QSR.  The QMSR, like the QSR, applies only to products that are marketed to customers within the U.S.A.

ISO 13485 offers broader applicability across global markets. Companies serving multiple international markets often find ISO 13485 provides a foundation that supports various national regulatory requirements while maintaining operational consistency.  ISO 13485 participation is voluntary, but can open markets for companies wishing to engage in international business.

Implementation Approach

QMSR compliance typically follows a regulatory-driven timeline. Companies must establish compliant systems before market entry, with ongoing maintenance driven by regulatory obligations and notified body surveillance.

ISO 13485 implementation usually follows business-driven timelines. Organizations can pursue certification when it aligns with their growth strategy, market expansion plans, or customer requirements.

Strategic Considerations for 2026

Market Access Requirements

Quality managers planning for 2026 must evaluate their target markets carefully. Companies focused exclusively on worldwide markets may prioritize ISO 13485 as their primary framework. However, any organization with U.S. market ambitions must ensure QMSR compliance regardless of other standards they maintain.  The good news is that the requirements for the QMSR and ISO 13485 are closely aligned, so compliance to ISO 13485 will get a company to approximately 85% compliance with the QMSR.

Operational Efficiency

Smart quality managers design integrated approaches that satisfy both frameworks efficiently. In the past, quality managers would have to maintain parallel systems for ISO 13485 and for QSR.  Now with QMSR companies can, successfully harmonize requirements into unified processes that address both QMSR and ISO 13485 together.  Due to the fact that the FDA has adopted ISO 13485 by reference, this simultaneously simplifies operations for medtech companies and integrates systems under a unified whole.

This integrated approach reduces documentation burden, streamlines training requirements, and minimizes audit complexity while ensuring comprehensive compliance.

Practical Implementation Recommendations

Assessment and Gap Analysis

The largest gap is for a company operating within the U.S. market that has not yet obtained ISO 13485 certification.  Because the QMSR focuses on effective risk management as the central concept of the standard, rather than management responsibility, the greatest challenge to switching from QSR to QMSR is to develop an integrated framework of risk management documentation.  This means that risk management plans form the backbone of the quality management system, and risks affecting patient safety, user safety, design control, must be assessed, documented, and regularly updated during the course of device development, manufacturing, and use.

This assessment should consider your company’s growth trajectory, target markets, and resource constraints to inform strategic prioritization.  Patient safety becomes the central identifying principle in a QMSR organization.  

Documentation and Training

Both frameworks demand robust documentation and training programs. Design these elements to support both standards efficiently, avoiding duplication while ensuring comprehensive coverage of all requirements.

Invest in training programs, such as those that CTI can provide, to help your team understand not just what each framework requires, but why these requirements exist and how they support broader business objectives.  Risk management training is essential to QMSR success.

Looking Ahead to 2026

The regulatory landscape continues evolving as medtech regulations 2026 implementations mature. Quality managers should anticipate increased scrutiny from regulatory bodies, enhanced post-market surveillance requirements, and growing emphasis on digital quality management solutions.

Companies that establish robust, integrated quality management systems now will be better positioned to adapt to future regulatory changes while maintaining operational efficiency and market competitiveness.

Final Thoughts

The choice between QMSR and ISO 13485 isn’t truly binary for most medtech companies. Success lies in understanding how these frameworks complement each other and designing quality management approaches that leverage both effectively.

Quality managers who view compliance as an enabler of growth rather than a burden will find opportunities to build systems that not only satisfy regulatory requirements but also drive operational excellence and competitive advantage.

The investment in comprehensive quality management pays dividends through reduced regulatory risk, improved operational efficiency, and enhanced customer confidence across global markets.

Ready to develop a strategic approach to QMSR and ISO 13485 compliance that supports your growth objectives?

Book a no-cost consultation with our regulatory experts to discuss your specific requirements and develop a customized compliance roadmap.